Neuvior Pharmaceuticals

Investor: Scottish Enterprise

Neuvior Pharmaceuticals has secured £99,000 in funding from Scottish Enterprise to support a feasibility study for its AI-enabled technology. Summary of transaction details: Value: £99,000 Sector: Pharmaceutical Advisor: None Key Entities: Neuvior Pharmaceuticals, Scottish Enterprise Location: Glasgow, Scotland Note: The funding will support Neuvior's nine-month feasibility study exploring how its artificial intelligence-enabled technology can help the NHS identify, assess and deploy generic medicines, and is a strategic move to support the development of AI-enabled technologies in the pharmaceutical sector.